ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1,4,Systemic mycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,2,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
5,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
6,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6,2,Injection site macule,Injection site reactions,Administration site reactions,Genrl,N
6,3,Injection site pallor,Injection site reactions,Administration site reactions,Genrl,N
6,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
7,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,2,Encephalitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,Y
7,3,Fungal sepsis,Fungal infections NEC,Fungal infectious disorders,Infec,N
8,1,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
8,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
9,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
10,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
11,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
12,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
13,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
14,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
15,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
16,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
16,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
17,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
17,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
18,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
18,3,Leriche syndrome,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,Y
18,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
18,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
18,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
19,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
20,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
21,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
22,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
23,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
24,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
25,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
25,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
25,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
25,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
26,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
26,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
26,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
26,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
26,6,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
26,7,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,Y
26,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
26,9,Peripheral nerve palsy,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
26,10,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
27,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
28,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
29,1,Jugular vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
30,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
30,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
31,1,Ileal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
31,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
32,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
32,2,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
32,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
32,4,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
33,1,Histoplasmosis,Histoplasma infections,Fungal infectious disorders,Infec,N
34,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
35,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
35,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
36,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
37,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
37,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
37,3,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
37,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
37,5,Transfusion-related acute lung injury,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
38,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
38,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
38,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
38,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
38,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
39,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
39,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
39,3,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
39,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
39,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
39,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
39,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
40,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
40,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
41,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
42,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
43,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
